Cross-Sectional Study "Patient Participation": Improving Efficacy and Identifying Mechanisms of Change through Participant Feedback

funded by the Federal Ministry of Education and Research (BMBF)

Principal Investigator IPU

Prof. Dr. Christiane Steinert

Principal Investigator (external)

Prof. Dr. Falk Leichsenring (Justus-Liebig Universität Gießen)

Project Description

The cross-sectional project "Patient Participation" is part of a multi-center study on the efficacy of therapy (ENHANCE), in which cognitive behavioral therapy (STAIR-Exposure), trauma-focused psychodynamic therapy (TF-PDT), and a "minimal attention" condition are compared with each other in the treatment of patients with posttraumatic stress disorder. The primary goal for ENHANCE is the development of effective therapies for people affected by PTSD.

"Patient Participation" aims to interview participants after successful interventions regarding the elements of the psychotherapy they found helpful or less helpful. For this purpose, 75 qualitative interviews will be conducted and analyzed using depth hermeneutics, content analysis and grounded theory.

The project follows a so-called mixed methods approach in which it combines quantitative data from the randomized controlled therapy study ENHANCE with qualitative investigations.

Original Language: German

Participating Researchers

Nina Marin (research associate, IPU Berlin)
Marie Siebert (research associate, IPU Berlin)
Freie Universität Berlin
Technische Universität Dresden
Justus-Liebig Universität Gießen
Johannes-Gutenberg Universität Mainz
Universität Ulm

Duration

Project Start: 01/2019
Project End: 12/2026

Publications

  • Leichsenring, F., Steinert, C., Beutel, M. E., Feix, L., Gündel, H., Hermann, A., ... & Hoyer, J. (2020). Trauma-focused psychodynamic therapy and STAIR Narrative Therapy of post-traumatic stress disorder related to childhood maltreatment: trial protocol of a multicentre randomised controlled trial assessing psychological, neurobiological and health economic outcomes (ENHANCE). BMJ open, 10(12), e040123.